Antibodies : Engineering and Therapeutics

  • Therapeutic Abs come from critical screenings of in vivo and in vitromethods
  • Bispecific Abs increase specificity and broaden the range of therapeutic MOA.
  • Optimized Ab leads undergo HFA, affinity maturation, and developability assessment.
  • Fc optimization is critical for antibody pharmacokinetics and pharmacodynamics

Related Conference of Antibodies : Engineering and Therapeutics

November 19-20, 2025

6th International Conference on Vaccine Research

Tokyo, Japan
December 22-23, 2025

7th World Congress on Vaccine and Immunology

Amsterdam, Netherlands
September 21-22, 2026

44th Euro Global Summit and Expo on Vaccines & Vaccination

Barcelona, Spain

Antibodies : Engineering and Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in